tiprankstipranks
Advertisement
Advertisement

ZNTL Stock Latest News

Zentalis announecs common stock offering, no amount given
The FlyZentalis announecs common stock offering, no amount given
17d ago
ZNTL
Zentalis 23M share Spot Secondary priced at $3.50
PremiumThe Fly
Zentalis 23M share Spot Secondary priced at $3.50
17d ago
ZNTL
Zentalis Pharmaceuticals Announces Major Common Stock Offering
PremiumCompany Announcements
Zentalis Pharmaceuticals Announces Major Common Stock Offering
19d ago
8K
ZNTL
Zentalis price target raised to $5 from $4 at Morgan Stanley
PremiumThe Fly
Zentalis price target raised to $5 from $4 at Morgan Stanley
26d ago
ZNTL
Regulatory Clarity and Trial Progress Support Azenosertib Outlook; Buy Rating Reiterated with Unchanged $10 Price Target
PremiumRatings
Regulatory Clarity and Trial Progress Support Azenosertib Outlook; Buy Rating Reiterated with Unchanged $10 Price Target
26d ago
ZNTL
Zentalis reports Q2 EPS (59c), consensus (48c)
PremiumThe FlyZentalis reports Q2 EPS (59c), consensus (48c)
27d ago
ZNTL
Zentalis Highlights Q2 Results and Azenosertib Progress
Premium
Company Announcements
Zentalis Highlights Q2 Results and Azenosertib Progress
27d ago
8K
ZNTL
Zentalis initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Zentalis initiated with a Buy at Rodman & Renshaw
1M ago
ZNTL
Zentalis initiated with an Outperform at Mizuho
PremiumThe Fly
Zentalis initiated with an Outperform at Mizuho
2M ago
ZNTL
Zentalis Shareholders Back Directors, Auditors and Executive Pay
PremiumCompany Announcements
Zentalis Shareholders Back Directors, Auditors and Executive Pay
3M ago
8K
ZNTL
Zentalis assumed with an Outperform at Oppenheimer
PremiumThe Fly
Zentalis assumed with an Outperform at Oppenheimer
3M ago
ZNTL
Zentalis Pharmaceuticals Expands Board, Appoints New Director
PremiumCompany Announcements
Zentalis Pharmaceuticals Expands Board, Appoints New Director
3M ago
8K
ZNTL
Analyst Reiterates Buy on Zentalis as New MUIR Data Bolster Azenosertib Outlook; $10 Price Target Unchanged
PremiumRatingsAnalyst Reiterates Buy on Zentalis as New MUIR Data Bolster Azenosertib Outlook; $10 Price Target Unchanged
3M ago
ZNTL
Zentalis Highlights Promising Azenosertib Data in Ovarian Cancer
Premium
Company Announcements
Zentalis Highlights Promising Azenosertib Data in Ovarian Cancer
3M ago
8K
ZNTL
Zentalis: Buy Rating Reiterated as Azenosertib Strategy Advances; $10 Price Target Maintained on De-Risked Dosing and Late-Stage Catalysts
Premium
Ratings
Zentalis: Buy Rating Reiterated as Azenosertib Strategy Advances; $10 Price Target Maintained on De-Risked Dosing and Late-Stage Catalysts
4M ago
ZNTL
Zentalis reports Q1 EPS (50c), consensus (52c)
PremiumThe Fly
Zentalis reports Q1 EPS (50c), consensus (52c)
4M ago
ZNTL
Zentalis Advances Azenosertib with New Trial Updates
PremiumCompany Announcements
Zentalis Advances Azenosertib with New Trial Updates
4M ago
8K
ZNTL
ZNTL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ZNTL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
ZNTL
Zentalis Starts Pivotal Phase 3 ASPENOVA Ovarian Cancer Trial
PremiumCompany Announcements
Zentalis Starts Pivotal Phase 3 ASPENOVA Ovarian Cancer Trial
4M ago
8K
ZNTL
Zentalis Highlights New Azenosertib Data in Breast Cancer
PremiumCompany AnnouncementsZentalis Highlights New Azenosertib Data in Breast Cancer
5M ago
8K
ZNTL
Zentalis to present azenosertib preclinical data in TNBC at AACR meeting
Premium
The Fly
Zentalis to present azenosertib preclinical data in TNBC at AACR meeting
5M ago
ZNTL
Midday Fly By: CoreWeave inks Anthropic, TSMC reports March sales bump
Premium
The Fly
Midday Fly By: CoreWeave inks Anthropic, TSMC reports March sales bump
5M ago
E
MU

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >